(19)
(11) EP 4 816 371 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24861322.6

(22) Date of filing: 28.11.2024
(51) International Patent Classification (IPC): 
C07D 471/04(2006.01)
A61K 31/506(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 471/04; A61P 35/00
(86) International application number:
PCT/CN2024/135245
(87) International publication number:
WO 2025/113558 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 29.11.2023 WO PCT/CN2023/134994

(71) Applicant: GENENTECH, INC.
South San Francisco, CA 94080 (US)

(72) Inventors:
  • ZHONG, Wenge
    Cambridge, Massachusetts 02142 (US)
  • ZHU, Xiaotian
    Cambridge, Massachusetts 02142 (US)
  • HU, Zhilong
    Shanghai 201210 (CN)
  • HE, Hu
    Shanghai 201210 (CN)
  • ZHANG, Fei
    Shanghai 201210 (CN)
  • LI, Zheng Jane
    Beijing 100176 (CN)
  • CHEN, Pengyuan
    Beijing 100176 (CN)
  • JIANG, Xiawei
    Beijing 100176 (CN)

(74) Representative: HGF 
HGF Limited 4th Floor, 1 City Square
Leeds LS1 2ES
Leeds LS1 2ES (GB)

   


(54) SALT AND SOLID FORMS OF A CDK INHIBITOR